Monday, June 22, 2020 5:45:26 PM
VANCOUVER, BRITISH COLUMBIA – June 22, 2020
Rubicon Organics Inc. (CSE:ROMJ) (OTCQX:ROMJF) (“Rubicon Organics” or the “Company”) is pleased to announce that it has signed a product supply agreement (the “Agreement”) with canacur GmbH, a medical cannabis distributor incorporated in Nuremburg, Germany (“Canacur”). Pursuant to the Agreement, Canacur shall purchase dried cannabis from Rubicon Organics for an initial term of three years, with two optional two-year extensions available. The Company expects first exports in the first half of 2021, pending EU-GMP certification.
“We are excited to bring our high-quality cannabis to German medical patients”, stated Jesse McConnell, CEO of Rubicon Organics. “This milestone agreement with Canacur provides another route to market and access to the fast-growing German medical market.”
As part of the Agreement, Canacur has agreed to provide the Company up to $700,000 as advance payment for product, which will be secured behind existing secured lenders on the Company’s facility in Delta, British Columbia. This advance payment assists the Company to prepare for EU-GMP processing and certification.
FEATURED Cannabix's Breath Logix Alcohol Device Delivers Positive Impact to Private Monitoring Agency in Montana, USA • Apr 25, 2024 8:52 AM
Bantec Reports an Over 50 Percent Increase in Sales and Profits in Q1 2024 from Q1 2023 • BANT • Apr 25, 2024 10:00 AM
Kona Gold Beverages, Inc. Announces Name Change to NuVibe, Inc. and Initiation of Ticker Symbol Application Process • KGKG • Apr 25, 2024 8:30 AM
Axis Technologies Group and Carbonis Forge Ahead with New Digital Carbon Credit Technology • AXTG • Apr 24, 2024 3:00 AM
North Bay Resources Announces Successful Equipment Test at Bishop Gold Mill, Inyo County, California • NBRI • Apr 23, 2024 9:41 AM
Epazz, Inc.: CryObo, Inc. solar Bitcoin operations will issue tokens • EPAZ • Apr 23, 2024 9:20 AM